Historical record - last NADAC publication: 3/21/2018
Product Information
HARVONI 90-400 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $1098.9375 per EA under NDC 61958180101. Its NADAC has been published 217 times since Jan 21, 2015.
Strength
90; 400 mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958180101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
3/21/2018
Active Ingredients
LEDIPASVIR; SOFOSBUVIRApproval Type
New Drug (NDA)
FDA Application
NDA205834On Market Since
10/10/2014
Pharmacological Classes
Price Statistics
The NADAC for HARVONI 90-400 MG TABLET has been published 217 times since Jan 21, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1098.9375 per EA |
|---|---|
| All-time high | $1101.1809 (Oct 11, 2017) |
| All-time low | $1084.6350 (Oct 18, 2017) |
| Median price | $1096.1906 |
| Average price | $1094.3722 |
| Largest weekly change | -1.5% (Oct 18, 2017) |
| Weeks tracked | 217 |
| Tracking since | Jan 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the LEDIPASVIR and SOFOSBUVIR market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HARVONI 90-400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HARVONI 90-400 MG TABLET, manufactured by Gilead Sciences, Inc., is $1098.9375 per EA (NDC 61958180101), effective Mar 13, 2019.
How has the price of HARVONI 90-400 MG TABLET changed over time?
Over the history we have for it, the NADAC for HARVONI 90-400 MG TABLET has held within roughly two percent of its current level. It has been tracked across 217 weekly CMS publications since Jan 21, 2015.
What are the highest and lowest recorded NADAC prices for HARVONI 90-400 MG TABLET?
Since Jan 21, 2015, the NADAC for HARVONI 90-400 MG TABLET has ranged from a low of $1084.6350 (Oct 18, 2017) to a high of $1101.1809 (Oct 11, 2017), with a median of $1096.1906 per EA.
Are there cheaper alternatives to HARVONI 90-400 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HARVONI 90-400 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures HARVONI 90-400 MG TABLET?
HARVONI 90-400 MG TABLET (NDC 61958180101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification